High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...
Purpose: The accurate diagnosis of prostate cancer (PCa) remains challenging, particularly because standard biopsy techniques do not routinely include anterior zone, leading to potential missed ...
MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...
A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.
Abstract: In the clinical diagnosis of prostate cancer, transrectal ultrasound (TRUS) is a commonly used examination method. Accurate segmentation of the prostate from TRUS images is crucial for ...
Abstract: Prostate cancer is the second most common cancer in men, and transrectal ultrasound (TRUS) guided biopsy is the standard method to diagnose prostate cancer. Accurate prostate segmentation in ...
Objective: To develop a machine learning-based model incorporating prostate-specific antigen (PSA) levels and prostate ultrasound video clips for diagnosing prostate cancer. Methods: The study ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Ultrasound (US) is widely used for guiding prostate biopsies ...
Prostate cancer diagnosis has seen a paradigm shift with the adoption of multiparametric magnetic resonance imaging (mpMRI) and its integration with transrectal ultrasound (TRUS) for targeted biopsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results